Search Results

There are 8039765 results for: content related to: Gemcitabine and docetaxel in metastatic, castrate-resistant prostate cancer

  1. You have free access to this content
    Phase II study of docetaxel re-treatment in docetaxel-pretreated castration-resistant prostate cancer

    BJU International

    Volume 107, Issue 2, January 2011, Pages: 234–239, Giuseppe Di Lorenzo, Carlo Buonerba, Adriana Faiella, Pasquale Rescigno, Mimma Rizzo, Riccardo Autorino, Sisto Perdonà, Nando Riccardi, Sarah Scagliorini, Florinda Scognamiglio, Daniele Masala, Matteo Ferro, Giovannella Palmieri, Michele Aieta, Alfredo Marinelli, Vincenzo Altieri, Sabino De Placido and Giacomo Cartenì

    Version of Record online : 29 JUN 2010, DOI: 10.1111/j.1464-410X.2010.09498.x

  2. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo

    The Prostate

    Volume 72, Issue 8, 1 June 2012, Pages: 856–867, J.Y. Henry, L. Lu, M. Adams, B. Meyer, J.B. Bartlett, Prof. A.G. Dalgleish and C. Galustian

    Version of Record online : 3 OCT 2011, DOI: 10.1002/pros.21488

  3. Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity

    The Prostate

    Volume 72, Issue 6, 1 May 2012, Pages: 661–667, Peter Makhov, Konstantin Golovine, Daniel Canter, Alexander Kutikov, Jay Simhan, Melany M. Corlew, Robert G. Uzzo and Vladimir M. Kolenko

    Version of Record online : 27 JUL 2011, DOI: 10.1002/pros.21469

  4. You have free access to this content
    Novel therapeutics for the management of castration-resistant prostate cancer (CRPC)

    BJU International

    Volume 109, Issue 7, April 2012, Pages: 968–985, Daniel J. Lee, Eugene K. Cha, Justin M. Dubin, Himisha Beltran, Thomas F. Chromecki, Harun Fajkovic, Douglas S. Scherr, Scott T. Tagawa and Shahrokh F. Shariat

    Version of Record online : 28 OCT 2011, DOI: 10.1111/j.1464-410X.2011.10643.x

  5. You have free access to this content
    Castration-resistant prostate cancer: Many treatments, many options, many challenges ahead

    Cancer

    Volume 118, Issue 10, 15 May 2012, Pages: 2583–2593, Jorge A. Garcia and Brian I. Rini

    Version of Record online : 28 OCT 2011, DOI: 10.1002/cncr.26582

  6. You have free access to this content
    New developments in castrate-resistant prostate cancer

    BJU International

    Volume 109, Issue s6, June 2012, Pages: 22–32, N. Shore, M. Mason and Th. M. de Reijke

    Version of Record online : 4 JUN 2012, DOI: 10.1111/j.1464-410X.2012.11217.x

  7. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  8. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  9. You have free access to this content
    Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12867

  10. Functional p53 determines docetaxel sensitivity in prostate cancer cells

    The Prostate

    Volume 73, Issue 4, March 2013, Pages: 418–427, Chengfei Liu, Yezi Zhu, Wei Lou, Nagalakshmi Nadiminty, Xinbin Chen, Qinghua Zhou, Xu Bao Shi, Ralph W. deVere White and Allen C. Gao

    Version of Record online : 19 SEP 2012, DOI: 10.1002/pros.22583

  11. Docetaxel Nanotechnology in Anticancer Therapy

    ChemMedChem

    Volume 7, Issue 6, June 2012, Pages: 952–972, Pengxiang Zhao and Didier Astruc

    Version of Record online : 19 APR 2012, DOI: 10.1002/cmdc.201200052

  12. You have free access to this content
    The role of docetaxel based therapy for prostate cancer in the era of targeted medicine

    International Journal of Urology

    Volume 17, Issue 3, March 2010, Pages: 228–240, Guru Sonpavde and Cora N Sternberg

    Version of Record online : 19 JAN 2010, DOI: 10.1111/j.1442-2042.2010.02449.x

  13. You have free access to this content
    Landmarks in non-hormonal pharmacological therapies for castration-resistant prostate cancer

    BJU International

    Volume 110, Issue s1, October 2012, Pages: 14–22, Noel W. Clarke

    Version of Record online : 10 OCT 2012, DOI: 10.1111/j.1464-410X.2012.11430.x

  14. The use of LC-MS to identify differentially expressed proteins in docetaxel-resistant prostate cancer cell lines

    PROTEOMICS

    Volume 12, Issue 13, July 2012, Pages: 2115–2126, Kathleen O'Connell, Maria Prencipe, Amanda O'Neill, Claire Corcoran, Sweta Rani, Michael Henry, Paul Dowling, Paula Meleady, Lorraine O'Driscoll, William Watson and Robert O'Connor

    Version of Record online : 17 JUL 2012, DOI: 10.1002/pmic.201100489

  15. You have free access to this content
    Dasatinib combined with docetaxel for castration-resistant prostate cancer

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 63–71, John C. Araujo, Paul Mathew, Andrew J. Armstrong, Edward L. Braud, Edwin Posadas, Mathew Lonberg, Gary E. Gallick, Géralyn C. Trudel, Prashni Paliwal, Shruti Agrawal and Christopher J. Logothetis

    Version of Record online : 4 MAR 2011, DOI: 10.1002/cncr.26204

  16. You have free access to this content
    Current and emerging treatment modalities for metastatic castration-resistant prostate cancer

    BJU International

    Volume 107, Issue s2, April 2011, Pages: 13–20, Sergio Bracarda, Christopher Logothetis, Cora N. Sternberg and Stéphane Oudard

    Version of Record online : 7 MAR 2011, DOI: 10.1111/j.1464-410X.2010.10036.x

  17. You have free access to this content
    Clinical development of novel therapeutics for castration-resistant prostate cancer

    CA: A Cancer Journal for Clinicians

    Volume 62, Issue 5, September/October 2012, Pages: 299–308, Matthew D. Galsky, Alexander C. Small, Che-kai Tsao and William K. Oh

    Version of Record online : 24 APR 2012, DOI: 10.3322/caac.21141

  18. You have free access to this content
    Optimizing the care of patients with advanced prostate cancer in the UK: current challenges and future opportunities

    BJU International

    Volume 110, Issue 5, September 2012, Pages: 658–667, Heather Payne, Amit Bahl, Malcolm Mason, Janis Troup and Johann De Bono

    Version of Record online : 19 MAR 2012, DOI: 10.1111/j.1464-410X.2011.10886.x

  19. You have free access to this content
    Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: The Australian perspective

    Asia-Pacific Journal of Clinical Oncology

    Volume 8, Issue 1, March 2012, Pages: 31–42, Phillip PARENTE, Francis PARNIS and Howard GURNEY

    Version of Record online : 28 FEB 2012, DOI: 10.1111/j.1743-7563.2011.01506.x

  20. You have free access to this content
    Population pharmacokinetics of intravenously and orally administered docetaxel with or without co-administration of ritonavir in patients with advanced cancer

    British Journal of Clinical Pharmacology

    Volume 69, Issue 5, May 2010, Pages: 465–474, Stijn L. W. Koolen, Roos L. Oostendorp, Jos H. Beijnen, Jan H. M. Schellens and Alwin D. R. Huitema

    Version of Record online : 28 JAN 2010, DOI: 10.1111/j.1365-2125.2010.03621.x